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1. Introduction
   Diabetes mellitus is caused by impaired insulin 
production and/or by decreased tissue response to the 
insulin[1]. The number of people with diabetes is increasing 
worldwide; 366 million people have diabetes, and 552 million 
people are expected to have diabetes by 2030[2]. During the 
pathogenesis of diabetes, mononuclear cells, infiltrating in 
and around the islets, generate excessive cytokines that up-
regulate inducible nitric oxide synthase (iNOS) expression 
and subsequently NO production, which impaires insulin 
secretion[3]. Insulin is a potent inducer of adipogenesis 
and enhances glucose uptake through activation of insulin 
signaling and glucose transporter (GLUT4) in adipocytes and 
myocytes[4]. So, glucose uptake in adipocytes and myocytes 
is decreased in insulin deficient state by defective insulin 
signaling. There is a wide variety of pharmacological 
drugs used to treat diabetes, including sulfonylureas, 
thiazolidinediones, biguanides, dipeptidyl peptidase (DPP)-
IV inhibitors, and α-glucosidase inhibitors. However, they 
are all associated with various side effects which limit them 
for long term use[5]. Most people in developing countries 
depend on alternative therapies, including natural 
resources for their primary health care[6]. However, such 
alternative therapies are not yet understood for diabetes and 
need to be better explored[7,8]. Marine algae have been used 
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as a functional food since prehistoric times. They are one 
of the less explored sources of pharmacological candidates, 
and few previous studies had found anti-diabetic activities 
in various marine algae[9].  
   Caulerpa lentillifera (C. lentillifera) is native to tropical 
areas of the Indian and Pacific Oceans, but it is currently 
discovered in the coast of Korea due to abnormal 
temperature. C. lentillifera is a popular edible species high 
in minerals, dietary fibers, vitamin A, vitamin C, and several 
essential unsaturated fatty acids, which is eaten fresh or 
salted for later use[10]. Recently, anti-cancer[11], anti-
oxidative[12], and lipid-lowering[13] activities of C. lentillifera 
extract have been documented. Also, C. lentillifera has 
been used traditionally in the Philippines for the treatment 
of diabetes. However, there are no experimental evidences. 
Therefore, our hypothesis is to investigate whether C. 
lentillifera extract increases insulin secretion and glucose 
uptake in pancreatic-β cells and adipocytes, respectively. 
To test the hypothesis, we measured the effect of C. 
lentillifera extract on DPP-IV and α-glucosidase enzymes 
using in vitro enzyme assay. Subsequently, we measured 
insulin secretion and glucose uptake in rat insulinoma (RIN) 
cells and 3T3-L1 adipocytes, respectively. 
 
2. Materials and methods
2.1. Reagents
   2-[N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl) amino]-
2-deoxyglucose (2-NBDG) was purchased from Invitrogen 
(Carlsbad, CA, USA). GLUT4 and iNOS antibodies were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). Gly-Pro-AMC was purchased from Ana Spec, Inc. (San 
Jose, CA, USA). Interleukin (IL)-1β and interferon (IFN)-γ 
were purchased from R & D (Minneapolis, MN, USA), and rat 
insulin ELISA kit was purchased from Mercodia Developing 
diagnostics (Mercodia, Uppsala, Sweden). All reagents were 
purchased from Sigma (St. Louis, MO, USA), unless otherwise 
specified.
2.2. Plant material
   C. lentillifera was imported through Marine Global Ltd. 
(Okinawa, Japan), which was farmed in the Phillippines. 
The algae was extensively washed with tap water, and dried 
at room temperature for 1 h after removal of the holdfasts 
and epiphytes. The dried C. lentillifera was extracted with 
ethanol for five times. Ethanol extract of C. lentillifera was 
then filtered, and evaporated under vacuum. The yield from 
the fresh dried sample was 2%. 
2.3. Measurement of DPP-IV and α-glucosidase activity
   An aliquot of 10 μL serum was incubated with 25 μL of 
50 mmol/L HEPES buffer (pH 7.4) containing the Gly-Pro-
AMC substrate (final substrate concentration 1 mmol/L). 
Appropriate concentration of the sample was mixed with 25 
μL of HEPES buffer. After 1 h incubation, the reaction was 
stopped by the addition of 70 μL of 3 mol/L acetic acid. Then, 
released AMC was measured using a fluorescence microplate 
reader, Perkin Elmer Victor3 V 1420 Multilabel Plate Counter 
(Perkin Elmer, USA) at an excitation wavelength of 370 nm 
and an emission wavelength of 440 nm. 
   Rat intestinal acetone powder was sonicated in normal 
saline (100:1, w/v), and after centrifugation at 3 000 r/min for 
30 min, the supernatant was treated as a crude intestinal 
α-glucosidase. Ten microliters of the test samples were 
mixed and incubated with 50 μL of enzyme in a 96-well 
microplate for 5 min. The reaction mixture was further 
incubated another 10 min with 50 μL substrate [5 mmol/L, 
p-nitrophenyl-d-glucopyranoside, prepared in 100 mmol/L 
phosphate buffer (pH 6.8)]. Finally, the reaction was stopped 
by adding 50 μL of sodium carbonate (100 mmol/L), and 
the released nitrophenol was measured at 405 nm using a 
spectrophotometer (Immuno Mini NJ-2300, Japan). 
2.4. Cell culture and cell viability assay
   RIN and 3T3-L1 cells, as models for pancreatic β-cells 
and adipocytes, were purchased from American Type 
Culture Collection (ATCC, Manassas, VA, USA), and grown in 
RPMI 1640 medium with 10% fetal bovine serum (FBS) and 
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal 
calf serum, respectively. To induce differentiation, 3T3-L1 
preadipocytes were cultured until confluence was reached 
(Day 0), and the culture medium was replaced with a fresh 
induction medium containing 5 μg/mL insulin, 0.5 mmol/L 
3-isobutyl-1-methylxanthine, and 1 μmol/L dexamethasone 
in DMEM with 10% FBS for 2 d. The medium was then replaced 
with a differentiation medium containing 5 μg/mL insulin 
and DMEM with 10% FBS every 2 d for up to 8 d until the cells 
were harvested. 
   The viability of cultured cells was assessed using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay. In brief, RIN (1伊105 cells/well) cells and 3T3-L1 
(1伊104 cells/well) cells seeded in 96-well plates were treated 
with respective concentrations of C. lentillifera extract 
for 48 h. Then, MTT solution (1 mg/mL) was added to each 
well, and the cells were incubated at 37 °C for 1 h. Finally, 
dimethyl sulfoxide was added to dissolve the formazan 
crystals. Absorbance was measured at 540 nm using a 
spectrophotometer (Immuno Mini NJ-2300, Japan). 
2.5. Measurement of NO production
   NO production was measured as a nitrite concentration 
in cell free culture supernatant using a colorimetric assay. 
Briefly, following treatment with sample and cytokines 
(IL-1β and IFN-γ) for 48 h, aliquots (100 μL) of culture 
supernatants were incubated with 100 μL of 1:1 mixture of 
1% sulfanilamide in 5% phosphoric acid and 0.1% N-(1-
naphthyl) ethyldiamine dihydrochloride at room temperature 
for 5 min, then absorbance at 540 nm was measured using 
a spectrophotometer (Immuno Mini NJ-2300, Japan). The 
concentration of NO was calculated by a linear standard 
curve generated from serial dilutions of sodium nitrite in 
working medium. 
2.6. Measurement of insulin secretion
   RIN cells were seeded at a density of 2伊105cells/well in 
24-well plates, and were treated with a sample (10 or 25 μg/
mL) and 100 μmol/L tolbutamide followed by treatment with 
cytokines for 48 h. Then, insulin released into the media 
was measured using the rat insulin ELISA kit according to 
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manufacturer’s instruction. The standard insulin provided in 
the kit was used to make the standard curve of insulin.  
2.7. Oil Red O staining
   Fully differentiated adipocytes were washed twice with 
phosphate buffer solution (PBS) and then fixed for 1 h at room 
temperature with 10% formalin, prepared in PBS. Then, cells 
were washed two times with PBS, and stained with a filtered 
Oil Red solution (0.5% in 60% isopropanol) for 1 h. Finally, 
cells were washed twice with distilled water, The fat droplets 
in 3T3-L1 adipocytes were observed by phase contrast 
microscopy. 
2.8. Glucose uptake assay
   3T3-L1 adipocytes grown in 96-black well plates were 
incubated with the sample (62.5 or 125 μg/mL) and 5 μmol/
L rosiglitazone (RSG) for 24 h at 37 °C in 5% CO2 atmosphere. 
Subsequently, 250 μmol/L 2-NBDG (dissolved in PBS with 1% 
bovine serum albumin) was added to the cells and incubated 
for further 30 min. After incubation, cells were washed two 
times with PBS to remove excess fluorescence in the wells. 
Then, fluorescence retained by the cells was measured using 
the fluorescence microplate reader, Perkin Elmer Victor3 
V 1420 Multilabel Plate Counter (Perkin Elmer, USA) at an 
excitation and emission wavelength of 485 nm and 535 nm, 
respectively.  
2.9. Western blot
   Cell lysates containing 30 μg of protein were separated 
by 10% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis. Then, it was transferred to nitrocellulose 
sheet in a western blot apparatus (Bio-Rad, Hercules, CA, 
USA). The nitrocellulose sheet was blocked with 5% skim 
milk for 1 h, rinsed by Tris-buffered-saline with Tween (1 
mol/L Tris, 5 mol/L NaCl, and 0.1% Tween 20), and incubated 
for overnight with primary antibodies of iNOS and GLUT4. 
Nitrocellulose membrane was again washed with Tris-
buffered-saline with Tween followed by incubation with 
secondary antibody (horseradish peroxidase-conjugated IgG 
1:2 000) for 1 h. Finally, the expressed proteins were measured 
by analyzing the signal captured in nitrocellulose membrane 
using chemiluminescent substrate and VisionWorksTMLS 
(Analysis software, Upland, CA, USA).
2.10. Statistical analysis
   SPSS (SPSS, Inc. Chicago, USA) was used for statistical data 
analysis. All data were presented as mean依SE. Groups were 
compared by using ANOVA, followed by Duncan’s post hoc 
test of multiple comparisons. P-values less than 0.05 were 
considered statistically significant.    
 
3. Results
3.1. Effect of C. lentillifera extract on DPP-IV and 
α-glucosidase enzyme inhibition
   DPP-IV inhibitors stimulated insulin secretion by regulating 
the release of incretin hormones, whereas α-glucosidase 
inhibitors decreased postprandial blood glucose by reducing 
the digestion of carbohydrates[14]. Inhibitory activities of C. 
lentillifera extract on DPP-IV and α-glucosidase enzymes are 
shown in Figure 1. C. lentillifera extract inhibited enzyme 
activity in a concentration-dependent manner, and 1 000 μg/
mL of the extract resulted in 46.1% and 42.9% inhibition of 
DPP-IV and α-glucosidase activity, respectively.  
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Figure 1. Effect of C. lentillifera extract on DPP-IV and α-glucosidase 
enzyme inhibition. 
Results are expressed as mean依SE of percent inhibition of three independent 
experiments. 
3.2. Effect of C. lentillifera extract on IL-1β and IFN-γ 
induced cell viability in RIN cells 
   The combination of IL-1β and IFN-γ caused pancreatic 
β-cell death, which is correlated with decreased insulin 
secretion in RIN cells. C. lentillifera extract did not affect 
cell cytotoxicity at concentration of 25 μg/mL (Figure 2A). As 
shown in Figure 2B, IL-1β and IFN-γ decreased cell viability 
to 44.8%. However, the addition of C. lentillifera extract (10 
and 25 μg/mL) increased cell viability by up to 61.3% and 
65.9%, respectively.  
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Figure 2. Effect of C. lentillifera extract on cytotoxicity (A) and IL-1β and 
IFN-γ induced cell viability (B) in RIN cells. 
RIN cells were incubated with sample for 48 h, and after 3 h of sample 
treatment RIN cells were exposed by IL-1β (2 ng/mL) and IFN-γ (100 IU/mL) 
for 48 h. Cell viability was determined by MTT assay. Each value represents 
the mean依SE of three independent experiments. Bars with different letters 
are significantly different at P<0.05 b in Duncan’s multi comparison tests.
3.3. Effect of C. lentillifera extract on IL-1β and IFN-γ 
induced NO production and iNOS expression in RIN cells 
   IL-1β and IFN-γ induced pancreatic β-cell death via NO 
production and iNOS expression[15]. As shown in Figure 3A, 
incubation of RIN cells with IL-1β and IFN-γ for 48 h resulted 
in significant production of NO (30.7 μmol/L). However, 10 
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and 25 μg/mL of C. lentillifera extract significantly decreased 
NO production in cytokine-induced RIN cells (from 30.7 
μmol/L to 24.7 and 21.6 μmol/L, respectively). Also, the 
concentration of 10 and 25 μg/mL of C. lentillifera extract 
dose-dependently inhibited expression of iNOS protein 
(Figure 3B). 
Concentration (μg/mL) Concentration (μg/mL)
Figure 3. Effect of C. lentillifera extract on IL-1β and IFN-γ induced NO 
production (A) and iNOS expression (B) in RIN cells. 
RIN cells were pretreated with indicated concentration of sample for 3 h, 
followed by stimulation with IL-1β (2 ng/mL) and IFN-γ (100 IU/mL) for 48 
h. Then, NO production and iNOS protein expression were determined by 
colorimetry and western blotting, respectively. Each value represents the 
mean依SE of three independent experiments. Bars with different letters are 
significantly different at P<0.05 in Duncan’s multi comparison tests.
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3.4. Effect of C. lentillifera extract on IL-1β and IFN-γ 
induced insulin secretion in RIN cells
   IL-1β and IFN-γ dramatically decreased insulin secretion 
from 13.5 to 6.2 ng/mL in RIN cells (Figure 4). However, 
the addition of 10 and 25 μg/mL of C. lentillifera extract 
efficiently increased insulin secretion from a baseline of 6.2 
to 10.7 and 12.0 ng/mL, respectively, which was comparable 
to the insulin secretory activity by tolbutamide as a positive 
control.
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Figure 4. Effect of C. lentillifera extract on IL-1β and IFN-γ induced insulin 
secretion in RIN cells. 
RIN cells were pretreated with indicated concentrations of sample for 3 h, 
followed by stimulation with IL-1β (2 ng/mL) and IFN-γ (100 IU/mL) for 48 h. 
Then, insulin secretion was determined in cell free culture supernatant by 
using Rat Insulin ELISA kit. About 100 μmol/L TLB was used as a standard 
drug. Each value represents the mean依SE of three independent experiments. 
Bars with different letters are significantly different at P<0.05 in Duncan’s 
multi comparison tests.  
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3.5. Effect of C. lentillifera extract on cell cytotoxicity and 
adipogenesis of 3T3-L1 cells
   As shown in Figure 5A, C. lentillifera extract did not 
cause cell cytotoxicity at the concentration of 125 μg/mL. 
Additionally, C. lentillifera extract significantly enhanced 
adipogenesis in a dose-dependent manner, which was 
comparable to RSG as an anti-diabetic drug (Figure 5B). 
Also, the Oil Red O content by C. lentillifera extract was 
significantly greater than that of control, and its value was 
comparable to RSG (Figure 5C). 
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Figure 5. Effect of C. lentillifera extrac on cytotoxicity (A), adipogenesis (B), 
and Oil Red O content (C) in 3T3-L1 cells. 
Confluent 3T3-L1 preadipocytes were differentiated into adipocytes for 8 
d in presence of sample, and cell viability was measured by MTT assay, 
adipogenesis was measured by staining with Oil Red O dye, and Oil Red O 
content was determined by measuring absorbance at 540 nm. RSG (5 μmol/
L) was used as a positive control. Each value represents the mean依SE of 
three independent experiments. Bars with different letters are significantly 
different at P<0.05 b in Duncan’s multi comparison tests.
3.6. Effect of C. lentillifera extract on glucose uptake and 
GLUT4 expression in 3T3-L1 cells
   The effect of C. lentillifera extract on glucose uptake was 
tested using fully differentiated adipocytes. As shown in 
Figure 6A, C. lentillifera extract significantly enhanced 
glucose uptake in a concentration-dependent manner. The 
results showed that C. lentillifera extract increased glucose 
uptake by 1.6 and 2 fold at 62.5 and 125 μg/mL, respectively. 
Similarly, C. lentillifera extract also increased GLUT4 
expression in a concentration-dependent manner (Figure 6B). 
The results showed that 125 μg/mL of C. lentillifera extract 
significantly increased GLUT4 expression by 1.4 fold, whereas 
5 μmol/L of RSG increased GLUT4 expression by 1.6 fold.  
Figure 6. Effect of C. lentillifera extract on glucose uptake (A) and GLUT4 
expression (B) in 3T3-L1 cells. 
Confluent 3T3-L1 preadipocytes were differentiated into adipocytes for 8 
d. Fully differentiated 3T3-L1 adipocytes were treated with sample for 24 
h, glucose uptake was measured using 2-NBDG, a fluorescent derivative of 
glucose as a glucose analogue by fluorometry, and GLUT4 expression was 
measured by western blot. RSG (5 μmol/L) was used as a positive control. 
Each value represents the mean依SE of three independent experiments. Bars 
with different letters are significantly different at P<0.05 in Duncan’s multi 
comparison tests.
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4. Discussion
   Diabetes is caused by diverse risk factors and is associated 
with abnormal metabolism of glucose. Ideal anti-diabetic 
agents not only preserve functional beta cell mass, but also 
enhance glucose uptake in most insulin target tissues[15]. In 
this study, we found that C. lentillifera extract significantly 
increased insulin secretion from RIN cells and enhanced 
glucose uptake in 3T3-L1 adipocytes. C. lentillifera extract 
preserved functional β-cell mass from cytokine-induced 
injury and decreased NO and iNOS production. Additionally, 
this study demonstrated that C. lentillifera extract increased 
preadipocyte differentiation, GLUT4 expression, and glucose 
uptake in mature adipocytes.  
   In cell culture systems, exposure to a mixture of cytokines 
released excessive NO production, caused death of pancreatic 
β-cells, and decreased insulin secretion. This mechanism 
is similar to the destruction of human pancreatic β-cells in 
type 1 diabetic patients[16]. We found that the treatment of 
RIN cells with cytokines increased iNOS expression and NO 
production, and decreased cell viability and insulin secretion. 
However, the addition of C. lentillifera extract protected RIN 
cells from cytokine-induced injuries and decreased NO and 
iNOS activation in a dose-dependent manner. In consistent 
with our results, Song et al. reported that Fructus Xanthii 
extract increases cell viability and decreases NO and iNOS 
production in cytokine-treated RIN cells[17]. Recently, several 
algal plants with high phenolic contents have been reported 
to have anti-diabetic activities in cell culture system and 
animal model system of diabetes, thereby intensifying insulin 
secretion, which is also similar to our results[18]. 
   Following the experiment on β-cells, we measured the 
effect of C. lentillifera extract on adipogenesis, glucose 
uptake, and GLUT4 expression in adipocytes as an insulin 
target tissue. Insulin signaling, after binding to its specific 
receptor in adipocytes, regulates the storage of free fatty 
acids in the form of triglyceride; however, massive adipocytes 
produce a number of adipocytokines such as tumor necrosis 
factor-α and IL-6 that consequently modulate insulin 
signaling with excess free fatty acids[19]. Therefore, adipocytes 
of type 2 diabetic patients are not capable of accumulating 
lipid, which results in insulin resistance[20]. Recently, anti-
diabetic activity of different seaweeds has been explored 
using 3T3-L1 adipocytes[21]. We discovered that C. lentillifera 
extract increased lipid accumulation, and significantly 
augmented glucose uptake and GLUT4 expression in 3T3-L1 
adipocytes. The ideal drugs for the treatment and prevention 
of diabetes should be capable of enhancing both insulin 
secretion and glucose uptake; however, most of the anti-
diabetic drugs either intensify insulin secretion in pancreatic 
β-cells or enhance glucose uptake in insulin sensitive 
tissues. Interestingly, we found that C. lentillifera extract not 
only enhances insulin secretion in pancreatic β-cells but 
also increases insulin sensitivity and glucose uptake in 3T3-
L1 adipocytes. 
   DPP-IV enzyme plays an important role in glucose 
metabolism by intensifying insulin secretion. It degrades 
incretin hormones, such as glucagon-like peptide-1 and 
gastric inhibitory polypeptide, that play an important role 
in insulin secretion from pancreatic β-cells[22]. Therefore, 
DPP-IV inhibitors had been developed as a new class of drug 
for the treatment of type 2 diabetes over the past few years. 
Guasch et al. found novel human DPP-IV inhibitors from 
extracts of plants known to have anti-diabetic effects[23]. In 
this study, we found that C. lentillifera extract inhibited both 
DPP-IV and α-glucosidase enzymes. 
   C. lentillifera, as a marine resource, contains a diverse type 
of chemical constituents, including from polyphenols and 
sterols to vitamins and minerals[13]. The synergistic action 
of such elements would augment anti-diabetic activities. 
However, to address the key issue of whether C. lentillifera 
extract could increase in-vivo insulin secretion and glucose 
uptake, animal based studies on its anti-diabetic activity 
and the phytochemical analysis are required. Our current 
study provides an inceptive stage in exploring anti-diabetic 
activity of C. lentillifera extract. Its mechanism is associated 
not only with an elevation of insulin secretion by prevention 
of NO and iNOS production from cytokine-induced RIN cells, 
but also with increased glucose uptake via GLUT4 expression 
in 3T3-L1 adipocytes.   
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Comments 
Background
   Diabetes mellitus is caused by impaired insulin production 
and/or by decreased tissue response to the insulin. The 
number of people with diabetes is increasing worldwide; 
366 million people have diabetes. There is a wide variety of 
pharmacological drugs used to treat diabetes. However, they 
are all associated with various side effects which limit them 
for long term use.
Research frontiers
   The author found that C. lentifera extract significantly 
decreased DPP-IV and alpha glucosidase enzyme 
activitiesand effectively inhibited cell death and iNOS 
expression in IL-1β and IFN-γ induced RIN cells. It was also 
effectively enhanced insulin secretion in RIN cells and GLUT4 
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epression and glucose uptake in 3T3-L1 adipocytes.
Related reports
   So far several works have been done on anti-diabetic 
activities from alga/seaweed, but for first time the present 
work revealed the anti-diabetics effect of C. lentifera. Hence 
the present work is considered to be the first report. The 
result also suggested the C. lentifera extract not only elevated 
insulin secretion but also increased glucose uptake in 3T3-L1 
adipocytes.
Innovations and breakthroughs
   Several researches were carried out on the anti-cancer, 
anti-oxidative and lipid-lowering properties of C. lentifera. 
In the present study, authors have extensively worked on the 
anti-diabetic effect of C. lentirafera on RIN cell and 3T3-L1 
adipocytes.
  
Applications
   The present study demonstrated the anti-diabetic 
properties from C. lentifera extract and may lead to further 
research on determining the responsible mechanims 
involved.
Peer review
   This is an ideal work to discover an alternative source 
for anti-diabetic agent. Authors comprehensively worked 
in anti-diabetic by using C. lentifera extract. The material 
and methods are well constructed and findings are well 
represented.
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